Dipna Pharmachem Ltd
DPLDipna Pharmachem Ltd
DPL
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| — | 0.46 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 51.92 | 6.65 | 0.51% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Dipna Pharmachem Limited trades and imports pharmaceutical raw materials and active ingredients, assisting in contract manufacturing compliance.
Peers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Torrent Pharmaceuticals Ltd
Mankind Pharma Ltd
Dr Reddy's Laboratories Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 16.57 | 20.19 | 30.55 | 31.02 | 72.77 | 99.94 | 164.34 | — | ||||||||
Raw Materials | 17.08 | 17.52 | 31.16 | 31.22 | 67.67 | 108.13 | 176.35 | — | ||||||||
| Power & Fuel Cost | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |||||||||
| Employee Cost | 0.00 | 0.00 | 0.38 | 0.41 | 0.00 | 0.00 | 0.00 | |||||||||
| Selling & Administrative Expenses | 0.70 | 0.63 | 0.61 | 0.54 | 1.66 | 1.92 | 2.77 | |||||||||
| Operating & Other expenses | -1.62 | 1.53 | -2.07 | -1.57 | 1.25 | -12.48 | -18.24 | |||||||||
EBITDA | 0.40 | 0.50 | 0.47 | 0.42 | 2.19 | 2.37 | 3.45 | — | ||||||||
| Depreciation/Amortization | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.02 | — | ||||||||
| PBIT | 0.40 | 0.49 | 0.46 | 0.41 | 2.18 | 2.36 | 3.43 | — | ||||||||
| Interest & Other Items | 0.33 | 0.43 | 0.39 | 0.35 | 0.61 | 0.97 | 2.01 | — | ||||||||
| PBT | 0.07 | 0.06 | 0.07 | 0.06 | 1.57 | 1.39 | 1.42 | — | ||||||||
| Taxes & Other Items | 0.01 | 0.02 | 0.00 | 0.03 | 0.41 | 0.47 | 0.34 | — | ||||||||
| Net Income | 0.06 | 0.04 | 0.07 | 0.03 | 1.16 | 0.92 | 1.08 | — | ||||||||
| EPS | 2.93 | 1.96 | 3.42 | 1.47 | 56.74 | 1.25 | 0.56 | — | ||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
Company Updates
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Dipna Pharmachem Ltd | 16.14 | 0.46 | — |
| Sun Pharmaceutical Industries Ltd | 45.12 | 6.44 | 0.75% |
| Cipla Ltd | 28.85 | 4.44 | 0.88% |
| Torrent Pharmaceuticals Ltd | 69.10 | 16.69 | 0.83% |
Price Comparison
Compare DPL with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
No institutional holdings trend are available
Shareholding Pattern
Sep 2023
Dec 2023
Mar 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
DPL has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeDipna Pharmachem will hold a meeting of the Board of Directors of the Company on 29 July 2024.Powered by Capital Market - Live
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 52.1%, vs industry avg of 9.03%
Increasing Market Share
Over the last 5 years, market share increased from 0.01% to 0.04%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 93.32%, vs industry avg of 15.27%